To check if rapamycin encapsulated within LNCs keeps its biological proprieties, human U87MG glioblastoma cells, that are PTEN negative and thus overactivate Akt/mTOR signals, were treated with empty LNCs, LNC-rapa and free rapamycin dissolved in DMSO. The gene discussed is AKT1; the disease is glioblastoma.